LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading MT
Koninklijke Philips N.V. (Royal Philips) to Issue 30.86 Million New Shares After Setting Dividend Exchange Ratio for 2023 MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
PHILIPS : Jefferies remains negative, but raises its target CF
PHILIPS NV : Jefferies remains a Sell rating ZD
Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio MT
PHILIPS NV : DZ Bank reiterates its Neutral rating ZD
Moody's Affirms Royal Philips' Rating, Upgrades Outlook on Enhanced Performance MT
UBS Upgrades Koninklijke Philips to Neutral From Sell MT
PHILIPS : Deutsche Bank upgrades recommendation to 'hold CF
PHILIPS NV : Barclays reiterates its Buy rating ZD
PHILIPS NV : Deutsche Bank reaffirms its Neutral rating ZD
PHILIPS : UBS raises its recommendation CF
PHILIPS NV : Goldman Sachs maintains a Buy rating ZD
PHILIPS NV : Deutsche Bank withdraws its Sell rating ZD
PHILIPS NV : UBS from Sell to Neutral ZD
PHILIPS NV : JP Morgan from Sell to Neutral ZD
ROYAL PHILIPS : The Dutch giant now poised for much better times Alphavalue
PHILIPS NV : Barclays remains its Buy rating ZD
ROYAL PHILIPS : Litigation uncertainty no longer an overhang; Q1 profitability beat Alphavalue
Tech Rally Subsides as US Equity Futures Waver Pre-Bell MT
Top Premarket Gainers MT
PHILIPS NV : UBS reiterates its Sell rating ZD
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook MT
European shares hit two-week high; inflation data, Fed meeting in focus RE
Chart Philips NV
More charts
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
25.87 EUR
Average target price
25.13 EUR
Spread / Average Target
  1. Stock Market
  2. Equities
  3. PHIA Stock
  4. News Philips NV
  5. Royal Philips: Philips’ recovery story remains intact
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.